Loop-mediated Isothermal Amplification and nested PCR of the Internal Transcribed Spacer (ITS) for Histoplasma capsulatum detection.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101291488 Publication Model: eCollection Cited Medium: Internet ISSN: 1935-2735 (Electronic) Linking ISSN: 19352727 NLM ISO Abbreviation: PLoS Negl Trop Dis Subsets: MEDLINE

Original Publication: San Francisco, CA : Public Library of Science

DNA, Ribosomal Spacer/*genetics ; Histoplasma/*isolation & purification ; Histoplasmosis/*diagnosis ; Molecular Diagnostic Techniques/*methods ; Nucleic Acid Amplification Techniques/*methods; Blood/microbiology ; Bone Marrow/microbiology ; Histoplasma/genetics ; Humans ; Prospective Studies ; Sensitivity and Specificity

Background: Histoplasmosis is a neglected disease that affects mainly immunocompromised patients, presenting a progressive dissemination pattern and a high mortality rate, mainly due to delayed diagnosis, caused by slow fungal growth in culture. Therefore, a fast, suitable and cost-effective assay is required for the diagnosis of histoplasmosis in resource-limited laboratories. This study aimed to develop and evaluate two new molecular approaches for a more cost-effective diagnosis of histoplasmosis.
Methodology: Seeking a fast, suitable, sensitive, specific and low-cost molecular detection technique, we developed a new Loop-mediated Isothermal Amplification (LAMP) assay and nested PCR, both targeting the Internal Transcribed Spacer (ITS) multicopy region of Histoplasma capsulatum. The sensitivity was evaluated using 26 bone marrow and 1 whole blood specimens from patients suspected to have histoplasmosis and 5 whole blood samples from healthy subjects. All specimens were evaluated in culture, as a reference standard test, and Hcp100 nPCR, as a molecular reference test. A heparin-containing whole blood sample from a heathy subject was spiked with H. capsulatum cells and directly assayed with no previous DNA extraction.
Results: Both assays were able to detect down to 1 fg/μL of H. capsulatum DNA, and ITS LAMP results could also be revealed to the naked-eye by adding SYBR green to the reaction tube. In addition, both assays were able to detect all clades of Histoplasma capsulatum cryptic species complex. No cross-reaction with other fungal pathogens was presented. In comparison with Hcp100 nPCR, both assays reached 83% sensitivity and 92% specificity. Furthermore, ITS LAMP assay showed no need for DNA extraction, since it could be directly applied to crude whole blood specimens, with a limit of detection of 10 yeasts/μL.
Conclusion: ITS LAMP and nPCR assays have the potential to be used in conjunction with culture for early diagnosis of progressive disseminated histoplasmosis, allowing earlier, appropriate treatment of the patient. The possibility of applying ITS LAMP, as a direct assay, with no DNA extraction and purification steps, makes it suitable for resource-limited laboratories. However, more studies are necessary to validate ITS LAMP and nPCR as direct assay in other types of clinical specimens.
Competing Interests: The authors have declared that no competing interests exist.

FEMS Microbiol Lett. 2018 Jun 1;365(11):. (PMID: 29648586)
Lancet Infect Dis. 2018 Oct;18(10):1150-1159. (PMID: 30146320)
J Clin Microbiol. 2001 Apr;39(4):1506-9. (PMID: 11283078)
J Clin Microbiol. 2003 Apr;41(4):1753-5. (PMID: 12682178)
J Clin Microbiol. 2008 Feb;46(2):713-20. (PMID: 18077626)
Clin Microbiol Rev. 2007 Jan;20(1):115-32. (PMID: 17223625)
Comput Appl Biosci. 1994 Apr;10(2):189-91. (PMID: 8019868)
Clin Vaccine Immunol. 2010 Jan;17(1):62-7. (PMID: 19940044)
Braz J Infect Dis. 2000 Apr;4(2):103-6. (PMID: 10797657)
Med Mycol Case Rep. 2013 Dec 14;4:1-4. (PMID: 24567897)
Biotechniques. 2009 Mar;46(3):167-72. (PMID: 19317660)
Mycoses. 2017 Jan;60(1):59-65. (PMID: 27625302)
Nucleic Acids Res. 2000 Jun 15;28(12):E63. (PMID: 10871386)
J Clin Microbiol. 2003 Mar;41(3):1295-8. (PMID: 12624071)
Mol Ecol. 2003 Dec;12(12):3383-401. (PMID: 14629354)
Lab Chip. 2015 Apr 21;15(8):1898-904. (PMID: 25715949)
J Clin Microbiol. 2014 Feb;52(2):483-8. (PMID: 24478477)
Mycoses. 2016 Jan;59(1):12-9. (PMID: 26578301)
J Med Microbiol. 2012 Dec;61(Pt 12):1688-95. (PMID: 22977075)
PLoS One. 2018 Jan 17;13(1):e0190408. (PMID: 29342162)
Mol Syst Biol. 2011 Oct 11;7:539. (PMID: 21988835)
Am J Trop Med Hyg. 2013 Nov;89(5):937-42. (PMID: 24043688)
J Clin Microbiol. 2003 Feb;41(2):535-9. (PMID: 12574242)
Clin Infect Dis. 2011 Sep;53(5):448-54. (PMID: 21810734)
Med Mycol. 2011 Nov;49(8):785-98. (PMID: 21539506)
Philos Trans R Soc Lond B Biol Sci. 2016 Dec 5;371(1709):. (PMID: 28080991)
Biotechniques. 2012 Aug;53(2):81-9. (PMID: 23030060)
Am J Trop Med Hyg. 2014 Feb;90(2):216-23. (PMID: 24394475)
AIDS. 2016 Jan;30(2):167-70. (PMID: 26684816)
Clin Infect Dis. 2001 Apr 15;32(8):1215-20. (PMID: 11283812)
Biochem Biophys Res Commun. 2001 Nov 23;289(1):150-4. (PMID: 11708792)
FEMS Immunol Med Microbiol. 2005 Sep 1;45(3):435-41. (PMID: 16061362)
Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6241-6. (PMID: 22454494)
Parasit Vectors. 2017 Jan 13;10(1):26. (PMID: 28086864)
FEMS Immunol Med Microbiol. 2011 Jun;62(1):41-8. (PMID: 21276085)
PLoS Negl Trop Dis. 2013 Nov 21;7(11):e2319. (PMID: 24278485)
Clin Vaccine Immunol. 2007 Dec;14(12):1587-91. (PMID: 17913863)
Trop Med Int Health. 2007 Sep;12(9):1108-15. (PMID: 17875020)
BMC Infect Dis. 2010 Sep 08;10:264. (PMID: 20825675)
Clin Infect Dis. 2000 Feb;30(2):328-35. (PMID: 10671337)
Diagn Microbiol Infect Dis. 2010 Mar;66(3):268-73. (PMID: 20159374)
PLoS Negl Trop Dis. 2014 Dec 04;8(12):e3290. (PMID: 25474641)
J Microbiol Methods. 2016 Nov;130:112-114. (PMID: 27633713)
Am J Trop Med Hyg. 2016 Oct 5;95(4):918-924. (PMID: 27481056)
Diagn Microbiol Infect Dis. 2007 Aug;58(4):441-4. (PMID: 17509796)
Rev Soc Bras Med Trop. 2010 Jan-Feb;43(1):27-31. (PMID: 20305964)
Rev Iberoam Micol. 2014 Jan-Mar;31(1):90-4. (PMID: 24270072)
Mol Biol Evol. 2016 Jul;33(7):1870-4. (PMID: 27004904)
Antimicrob Agents Chemother. 2010 Sep;54(9):3978-9. (PMID: 20566767)
Biotechniques. 2015 Feb 01;58(2):59-68. (PMID: 25652028)
J Clin Microbiol. 2002 May;40(5):1644-7. (PMID: 11980934)
PLoS Negl Trop Dis. 2016 Jun 01;10(6):e0004732. (PMID: 27248851)
Clin Vaccine Immunol. 2011 Apr;18(4):661-6. (PMID: 21307278)
Mycoses. 1998 Nov;41(9-10):355-62. (PMID: 9916456)
Rev Soc Bras Med Trop. 2001 Sep-Oct;34(5):483-6. (PMID: 11600916)
Mycoses. 2014 May;57(5):299-306. (PMID: 24299459)
J Bacteriol. 1998 Dec;180(24):6697-703. (PMID: 9852017)
Anal Chem. 2016 Apr 5;88(7):3562-8. (PMID: 26980448)
Rev Soc Bras Med Trop. 2008 May-Jun;41(3):247-51. (PMID: 18719803)
J Clin Microbiol. 2011 Sep;49(9):3204-8. (PMID: 21752970)
J Clin Microbiol. 1997 Sep;35(9):2252-5. (PMID: 9276396)

0 (DNA, Ribosomal Spacer)

Date Created: 20190827 Date Completed: 20200107 Latest Revision: 20200309

20240829

PMC6730939

10.1371/journal.pntd.0007692

31449526